Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-101610
Filing Date
2024-11-22
Accepted
2024-11-22 16:16:10
Documents
1
Period of Report
2024-11-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4574
  Complete submission text file 0001213900-24-101610.txt   6213
Mailing Address 677 N. WASHINGTON BLVD SARASOTA FL 34236
Business Address 677 N. WASHINGTON BLVD SARASOTA FL 34236 (718) 400-9031
Silo Pharma, Inc. (Issuer) CIK: 0001514183 (see all company filings)

EIN.: 462137136 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 285 GRAND AVENUE ENGLEWOOD NJ 07631
Business Address
Weisblum Eric (Reporting) CIK: 0001569077 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41512 | Film No.: 241489953